Table 1.
Clinical Data of Patients Carrying ANO5 Mutations
Phenotype | Fam-IDa | Ethnic Bckg | Sex | ANO5 Mutations (gDNA) | Age (2009) | Age of Onset | Distal Weakness Arm | Iliops. MRC | Quad. Atrophy | Quad. MRC | Calf Muscles | Distal Weakness Leg | Loss of Walking | Maximum CK (IU) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LGMD2L | IX-II-321 | FC | F | c.1295C>Gb | 68 | AS | none | 4/5 | + | 5/5 | none | none | no | 1,649 |
LGMD2L | IX-II-421 | FC | M | c.1295C>Gb | 67 | 40 | none | 4/5 | + | 4.5/5 | mild atrophy | none | no | 1,032 |
LGMD2L | IX-II-521 | FC | M | c.1295C>Gb | 65 | 37 | none | 4/5 | + | 4/5 | mild atrophy | none | no | 1,156 |
LGMD2L | IX-II-921 | FC | M | c.1295C>Gb | 47 | 20 | none | 4/5 | + | 5/5 | mild atrophy | none | no | 6,000 |
LGMD2L | XXXI-II-11 | FC | M | c.1295C>Gb | 43 | 20 | none | 4/5 | + | 5/5 | atrophy | calf muscles 4/5 | no | 8,081 |
LGMD2L | XXXI-II-3 | FC | F | c.1295C>Gb | 61 | AS | none | 4.5/5 | - | 5/5 | hypertrophy | none | no | 4,061 |
LGMD2L | XXIX-II-1 | FC | F | c.191 dupA/c.692G>T | 64 | 55 | none | 3.5/5 | + | 4.5/5 | hypertrophy | tibialis ant.4/5 | no | 1,339 |
MMD3 | H-II-624 | Fin | M | c.2272C>Tb | 44 | 20 | none | Sin 4/5 | + | 4/5/2/5 | hypertrophy | calf muscles 2/5 | no | 15,860 |
MMD3 | H-II-424 | Fin | M | c.2272C>Tb | 50 | 25 | none | 5/5 | - | 5/5 | hypertrophy | calf muscles 4/5 | no | 12,290 |
MMD3 | IV-II-123 | Du | M | c.191 dupAb | 72 | 51 | none | 4/5 | - | 4/5 | none | calf muscles 2/5 | no | 5,400 |
MMD3 | IV-II-423 | Du | M | c.191 dupAb | 67 | 45 | none | 5/5 | + | 5/5 | none | calf muscles 2/5 | no | 4,500 |
MMD3 | IV-II-1223 | Du | M | c.191 dupAb | 53 | 39 | none | 5/5 | - | 5/5 | none | calf muscles 2/5 | no | 4,800 |
Means | 37 | 5,514 |
Abbreviations: Ethnic bckg, ethnic background; FC, French Canadian; Fin, Finnish; Du, Dutch; AS, asymptomatic; Quad., quadriceps; Iliops., iliopsoas; MRC, Medical Research Council muscle strength scale; Tibialis ant., Tibialis anterior
Families IX, H, and IV refer to original articles (see 21,23,24).
Patients homozygous for the mutation.